Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Taguchi

Showing results (751-760 of 978) with videos related to

Pageof 98
Sort By:
European Journal of Immunology|January 1, 1992
Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalitiesW K Aicher, K Fujihashi, T Taguchi, et al.
Anticancer Research|May 1, 1997
Mechanism of growth inhibition by calpain inhibitor in MCF-7 cellsE Shiba, S J Kim, J Kambayashi, et al.
Biochemistry|January 20, 2017
Glutamate 350 Plays an Essential Role in Conformational Gating of Long-Range Radical Transport in Escherichia coli Class Ia Ribonucleotide ReductaseKanchana Ravichandran, Ellen C Minnihan, Qinghui Lin, et al.
Anticancer Research|May 1, 1997
Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical studyS J Kim, E Shiba, H Ishii, et al.
Neurology|August 1, 1987
Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neuronsC E Henderson, S L Hauser, M Huchet, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Proof that the ACTVI genetic region of Streptomyces coelicolor A3(2) is involved in stereospecific pyran ring formation in the biosynthesis of actinorhodinK Ichinose, C Surti, T Taguchi, et al.
Endocrine Journal|July 8, 1999
Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasiaT Watanabe, F Tsukamoto, T Shimizu, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonistsA Nakazato, T Kumagai, K Sakagami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1994
[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer]T Taguchi, Y Yoshida, M Izuo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1996
[An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II]M Fukuoka, K Noda, K Hasegawa, et al.
Pageof 98

Showing results (751-760 of 978) with videos related to

Sort By:
Pageof 98
European Journal of Immunology|January 1, 1992
Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalitiesW K Aicher, K Fujihashi, T Taguchi, et al.
Anticancer Research|May 1, 1997
Mechanism of growth inhibition by calpain inhibitor in MCF-7 cellsE Shiba, S J Kim, J Kambayashi, et al.
Biochemistry|January 20, 2017
Glutamate 350 Plays an Essential Role in Conformational Gating of Long-Range Radical Transport in Escherichia coli Class Ia Ribonucleotide ReductaseKanchana Ravichandran, Ellen C Minnihan, Qinghui Lin, et al.
Anticancer Research|May 1, 1997
Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical studyS J Kim, E Shiba, H Ishii, et al.
Neurology|August 1, 1987
Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neuronsC E Henderson, S L Hauser, M Huchet, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Proof that the ACTVI genetic region of Streptomyces coelicolor A3(2) is involved in stereospecific pyran ring formation in the biosynthesis of actinorhodinK Ichinose, C Surti, T Taguchi, et al.
Endocrine Journal|July 8, 1999
Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasiaT Watanabe, F Tsukamoto, T Shimizu, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonistsA Nakazato, T Kumagai, K Sakagami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1994
[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer]T Taguchi, Y Yoshida, M Izuo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1996
[An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II]M Fukuoka, K Noda, K Hasegawa, et al.
Pageof 98